UBS Group’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,188
| Closed | -$11K | – | 11413 |
|
|
2021
Q3 | $11K | Sell |
5,188
-21,261
| -80% | -$49.5K | ﹤0.01% | 7969 |
|
|
2021
Q2 | $79K | Buy |
26,449
+10,243
| +63% | +$27K | ﹤0.01% | 6065 |
|
|
2021
Q1 | $45K | Sell |
16,206
-3,094
| -16% | -$9.34K | ﹤0.01% | 6671 |
|
|
2020
Q4 | $46K | Buy |
19,300
+14,590
| +310% | +$35.1K | ﹤0.01% | 6274 |
|
|
2020
Q3 | $10K | Sell |
4,710
-11,778
| -71% | -$39.7K | ﹤0.01% | 6891 |
|
|
2020
Q2 | $63K | Sell |
16,488
-8,553
| -34% | -$25.6K | ﹤0.01% | 5685 |
|
|
2020
Q1 | $47K | Sell |
25,041
-23,986
| -49% | -$62.3K | ﹤0.01% | 5889 |
|
|
2019
Q4 | $102K | Buy |
49,027
+24,486
| +100% | +$46.9K | ﹤0.01% | 6002 |
|
|
2019
Q3 | $59K | Buy |
24,541
+20,841
| +563% | +$56K | ﹤0.01% | 6108 |
|
|
2019
Q2 | $12K | Sell |
3,700
-503
| -12% | -$1.85K | ﹤0.01% | 6978 |
|
|
2019
Q1 | $21K | Buy |
4,203
+1,858
| +79% | +$9.15K | ﹤0.01% | 6294 |
|
|
2018
Q4 | $11K | Buy |
2,345
+1,896
| +422% | +$9.26K | ﹤0.01% | 7209 |
|
|
2018
Q3 | $2K | Buy |
+449
| New | +$2.3K | ﹤0.01% | 7780 |
|
|
2018
Q1 | – | Sell |
-264
| Closed | -$2K | – | 8327 |
|
|
2017
Q4 | $2K | Sell |
264
-2,576
| -91% | -$16.1K | ﹤0.01% | 7654 |
|
|
2017
Q3 | $20K | Buy |
+2,840
| New | +$19.6K | ﹤0.01% | 6464 |
|
|
2016
Q4 | – | Sell |
-751
| Closed | -$4K | – | 8157 |
|
|
2016
Q3 | $4K | Sell |
751
-1,326
| -64% | -$5.98K | ﹤0.01% | 7227 |
|
|
2016
Q2 | $8K | Sell |
2,077
-892
| -30% | -$4.21K | ﹤0.01% | 6921 |
|
|
2016
Q1 | $14K | Buy |
2,969
+46
| +2% | +$207 | ﹤0.01% | 6462 |
|
|
2015
Q4 | $22K | Buy |
+2,923
| New | +$21K | ﹤0.01% | 6672 |
|
UBS Group's SBBP Position: Q4 2021 in Review
UBS Group sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 5,188 shares — an estimated $11K sold.
UBS Group first reported a position in SBBP in Q4 2015 and held it in 19 quarters. The position peaked at $102K in Q4 2019. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- UBS Group reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- UBS Group sold 5,188 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $11K.
- UBS Group first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 19 quarters.
- UBS Group's Strongbridge Biopharma plc. position peaked at $102K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.